Rajesh Kumar

Q: What is Rajesh Kumar's success rate?

Rajesh Kumar currently has a success rate of 87.054244098443.

Q: What is the average return of Rajesh Kumar's calls?

Their stock ratings have generated an average return of 10.589110380491183.

HSBC | Healthcare

Rajesh Kumar is an analyst from HSBC specializing in the Healthcare sector. Ranked #1832 out of 4580 analysts, they have issued 8 stock ratings with a success rate of 87.05% and an average return of 10.59%.

With 8 ratings to date, Rajesh Kumar is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 87.05% and an average return of 10.59%, highlighting promising potential as their track record develops further.

#1832

Out of 4580

Total Ratings

+87.05%

Success Rate

+10.59%

Average Return

Recent Ratings Analysis

PFE

Buy

Mar 17, 2026

Target

$32.00

Current

$27.47

Performance

0.07%

Rajesh Kumar rated PFE as Buy on Mar 17, 2026, setting a price target of 32. Shares have remained stable near 27.47, leaving the 32 target still in play.

BIIB

Sell

Mar 17, 2026

Target

$150.00

Current

$185.29

Performance

0.00%

On Mar 17, 2026, BIIB was given a Reduce rating by Rajesh Kumar, with a target price of 150. The stock traded sideways with only a 0.00% move, leaving the Sell case unresolved.

BMY

Hold

Mar 17, 2026

Target

$60.00

Current

$59.71

Performance

0.00%

BMY received a Hold rating from Rajesh Kumar on Mar 17, 2026, aiming for 60. Shares remained flat at 59.71, aligning with the neutral rating.

LLY

Sell

Mar 17, 2026

Target

$850.00

Current

$930.51

Performance

0.02%

On Mar 17, 2026, Rajesh Kumar published a Reduce outlook on LLY, with a target of 850. The rating remains inconclusive as the market consolidates near 930.51.

ABBV

Buy

Dec 10, 2025

Target

$265.00

Current

$219.77

Performance

-2.40%

Rajesh Kumar on Dec 10, 2025 assigned ABBV a Buy rating, with a price target of 265. The recommendation remains pending validation as shares consolidate around 219.77.

NVO

Hold

Nov 24, 2025

Target

$0.00

Current

$38.43

Performance

-14.54%

On Nov 24, 2025, Rajesh Kumar reaffirmed NVO with a Hold rating, targeting null. The Hold stance reflected market caution that was later justified.

IQV

Buy

Oct 09, 2025

Target

$235.00

Current

$168.43

Performance

-17.03%

IQV was rated Buy by Rajesh Kumar on Oct 09, 2025, with a price objective of 235. This case shows how bullish projections can fail, with the stock now below 168.43.

TMO

Buy

Apr 30, 2024

Target

$670.00

Current

$472.71

Performance

-16.88%

On Apr 30, 2024, Rajesh Kumar initiated coverage on TMO with a Buy rating and target of 670. The Buy call has yet to be validated as shares remain 197.29 away from the target.

Frequency Asked Questions

Who is Rajesh Kumar?

Rajesh Kumar is an analyst from HSBC specializing in the Healthcare sector.

What is Rajesh Kumar's success rate?

Rajesh Kumar currently has a success rate of +87.05%.

How many ratings has Rajesh Kumar issued?

Rajesh Kumar has issued 8 stock ratings so far.

What is the average return of Rajesh Kumar's calls?

Their stock ratings have generated an average return of +10.59%.

What is Rajesh Kumar's ranking?

Rajesh Kumar is ranked #1832 out of 4580 analysts.

What types of ratings does Rajesh Kumar give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Rajesh Kumar?

You can follow Rajesh Kumar by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Rajesh Kumar?

Their latest rating was a Buy on PFE issued on 2026-03-17.